HHH Shorts Rebuild While Pershing Square Anchors the Register
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Howard Hughes Holdings heads into its November 5 earnings with a notable contradiction: short sellers have rebuilt positions at the fastest monthly pace in recent memory, yet the stock is quietly grinding higher and the dominant shareholder shows no signs of moving.
The short-interest story is the most pressing tension right now. Bears have added meaningfully over the past month, with short interest climbing 21% in 30 days to reach 7.5% of free float. That is a material build for a mid-cap real estate developer, and it happened steadily rather than in a single session. The week-on-week change is a more modest 1%, suggesting the pace of accumulation may be plateauing. Crucially, the borrow market is not flashing distress. Cost to borrow is just 0.50%, down roughly 9% on the week, and availability sits at 274%, meaning there are nearly three shares available to borrow for every share already short. Bears can add without friction.
Options positioning reinforces the cautious tone in a more pronounced way. The put/call ratio is running at 1.35, close to its 52-week high of 1.37 and well above its 20-day average of 1.11. That ratio jumped sharply from below 0.80 in late September, a shift that coincided almost exactly with the short-interest build. Together, they point to a market that has turned more defensive on this name into the earnings date, even as the stock itself is up 6% over the past month to $70.19. The ORTEX short score sits at 67.8, towards the higher end of its recent range, consistent with above-average bearish pressure without tipping into extreme territory.
The Street's posture reflects a similar ambivalence. Piper Sandler maintained its Overweight rating on October 12 but cut its price target sharply, from $100 to $83. That is a meaningful reduction even as the firm held its constructive view, suggesting growing uncertainty about the path to realising net asset value. JP Morgan sits at Neutral with a $79 target. The consensus mean sits at $84, implying roughly 20% upside from the current price. The bull case rests on NAV accretion: the company has sold 4,000 acres for $2.7 billion since 2017 while gross asset value has still risen from $3.7 billion to $4.8 billion, a land-appreciation story that has broadly worked. Bears point to the revenue concentration in master planned community land sales across cyclically sensitive markets including Las Vegas, Houston, and Phoenix, where demand can shift quickly. On valuation, EV/EBITDA is running at 14.3x with the price-to-book at 0.82x, modest for a real estate developer sitting on appreciating land.
The ownership structure is the most distinctive fact about this stock. Pershing Square Capital Management holds 46.7% of the class, a 13D activist filing, and has filed twelve times since initially disclosing in January 2025. The stake was unchanged in the most recent filing as of June 2026. With nearly half the float controlled by one activist, the free float available to trade is structurally compressed, which partly explains why a short position of 7.5% of float can exist alongside ample borrow availability: the lending pool draws heavily from institutional holders outside of Pershing. Dimensional Fund Advisors disclosed a fresh 5.1% passive stake as recently as October 8, adding a second significant holder to a register that is already concentrated. On the open-market buying side, the company's COO and Marc Grandisson, Executive Chairman of Vantage, both made discretionary purchases in late September at prices around $64, totalling roughly $1.67 million combined. Neither trade was under a 10b5-1 plan, and both occurred below the current price.
At the last two earnings prints, the stock fell roughly 3.7% on the day and continued lower over the subsequent week. The print before that produced a small gain. The pattern is not one-sided, but recent reactions have leaned negative, and the current options positioning into November 5 appears to price in more of the same caution.
What to watch is whether the short build holds above 7% of float into the print or begins to unwind as longs point to the insider purchases and NAV momentum, and whether Piper Sandler's target cut proves to be the floor on Street estimates or the start of a broader revision lower.
Stocks in this article
See the live data behind this article on ORTEX.
Open HHH on ORTEX →How this article was generated
- Generated
- 24 Oct 2026, 20:14
- Data as of
- 24 Oct 2026, 20:14
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.